Key result
PKC activation with PMA in isolated rat hearts decreased PVA-independent VO2 by 28% and increased contractile efficiency by 41% (P<0.05), effects that were abolished by chelerythrine.
Why the study?
Does PKC activation with PMA alter myocardial O2 consumption and contractile efficiency in isolated rat hearts?
Population
Isolated rat hearts
Comparison
PKC activator phorbol 12-myristate 13-acetate… vs Baseline or hearts without PMA/chelerythrine
Design
Preclinical
Authors
Loading...
No clinical implications from this rat model; extends mechanistic evidence on PKC and myocardial efficiency.
Does PKC activation with PMA alter myocardial O2 consumption and contractile efficiency in isolated rat hearts?
p-value: p=<0.05
PKC activation by PMA decreases myocardial oxygen consumption and increases contractile efficiency in isolated rat hearts, effects that are reversed by PKC inhibition.
Noguchi et al. (2001) studied cardiac mechanoenergetics. Phorbol 12-myristate 13-acetate (PMA) with or without chelerythrine vs. Baseline/Control was evaluated on Contractile efficiency and PVA-independent VO2 (p=<0.05). PKC activation with PMA in isolated rat hearts decreased PVA-independent VO2 by 28% and increased contractile efficiency by 41% (P<0.05), effects that were abolished by chelerythrine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: